Global Nuclear Medicine & Radiopharmaceuticals Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Nuclear Medicine & Radiopharmaceuticals is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Nuclear Medicine & Radiopharmaceuticals market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Nuclear Medicine & Radiopharmaceuticals industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Nuclear Medicine & Radiopharmaceuticals Market Segmentations:

    By Players:

    • Bracco Imaging

    • Bayer

    • Nordion

    • Dongcheng

    • Lantheus

    • Advanced Accelerator Applications

    • Navidea

    • GE Healthcare

    • Jubilant Pharma

    • Mallinckrodt

    • Triad Isotopes

    • SIEMENS

    • Eli Lilly

    • China Isotope & Radiation

    • IBA Group

    By Types:

    • Diagnostic Radioisotopes

    • Therapeutic Radioisotopes

    By End-User:

    • Oncology

    • Cardiology

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine & Radiopharmaceuticals Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

      • 1.3.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2014 to 2026

      • 1.4.3 Global Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Nuclear Medicine & Radiopharmaceuticals Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine & Radiopharmaceuticals by Major Types

      • 3.4.1 Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Radioisotopes

      • 3.4.2 Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Radioisotopes

    4 Segmentation of Nuclear Medicine & Radiopharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine & Radiopharmaceuticals by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Nuclear Medicine & Radiopharmaceuticals in Oncology

      • 4.4.2 Market Size and Growth Rate of Nuclear Medicine & Radiopharmaceuticals in Cardiology

      • 4.4.3 Market Size and Growth Rate of Nuclear Medicine & Radiopharmaceuticals in Other

    5 Market Analysis by Major Regions

    • 5.1 Global Nuclear Medicine & Radiopharmaceuticals Production Analysis by Major Regions

    • 5.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Analysis by Major Regions

    • 5.3 Global Nuclear Medicine & Radiopharmaceuticals Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Nuclear Medicine & Radiopharmaceuticals Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    6 Product Commodity of Nuclear Medicine & Radiopharmaceuticals Market in Major Countries

    • 6.1 Top 5 Export Countries in Nuclear Medicine & Radiopharmaceuticals market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Nuclear Medicine & Radiopharmaceuticals market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Nuclear Medicine & Radiopharmaceuticals market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Nuclear Medicine & Radiopharmaceuticals market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Nuclear Medicine & Radiopharmaceuticals market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Nuclear Medicine & Radiopharmaceuticals market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Nuclear Medicine & Radiopharmaceuticals Landscape Analysis

    • 7.1 North America Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major Types

    • 7.2 North America Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major End-Users

    • 7.3 North America Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major Countries

      • 7.3.1 United States Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 7.3.2 Canada Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 7.3.3 Mexico Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

    8 Europe Nuclear Medicine & Radiopharmaceuticals Landscape Analysis

    • 8.1 Europe Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major Types

    • 8.2 Europe Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major End-Users

    • 8.3 Europe Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major Countries

      • 8.3.1 Germany Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.2 UK Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.3 France Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.4 Italy Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.6 Spain Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.7 Belgium Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.8 Poland Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.9 Russia Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.10 Turkey Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

    9 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Landscape Analysis

    • 9.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major Types

    • 9.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major Countries

      • 9.3.1 China Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 9.3.2 Japan Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 9.3.4 India Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 9.3.6 South Korea Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 10.3.2 Brazil Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 10.3.3 Nigeria Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

      • 10.3.4 South Africa Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate 

      • 10.3.5 Argentina Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Bracco Imaging

      • 11.1.1 Bracco Imaging Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Bayer

      • 11.2.1 Bayer Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Nordion

      • 11.3.1 Nordion Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Dongcheng

      • 11.4.1 Dongcheng Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Lantheus

      • 11.5.1 Lantheus Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Advanced Accelerator Applications

      • 11.6.1 Advanced Accelerator Applications Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Navidea

      • 11.7.1 Navidea Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 GE Healthcare

      • 11.8.1 GE Healthcare Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Jubilant Pharma

      • 11.9.1 Jubilant Pharma Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Mallinckrodt

      • 11.10.1 Mallinckrodt Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Triad Isotopes

      • 11.11.1 Triad Isotopes Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 SIEMENS

      • 11.12.1 SIEMENS Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Eli Lilly

      • 11.13.1 Eli Lilly Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 China Isotope & Radiation

      • 11.14.1 China Isotope & Radiation Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 IBA Group

      • 11.15.1 IBA Group Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 80 Figures and 185 Tables)

    • Figure Product Picture

    • Figure Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

    • Figure Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Nuclear Medicine & Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine & Radiopharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine & Radiopharmaceuticals

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine & Radiopharmaceuticals by Different Types from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine & Radiopharmaceuticals by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Diagnostic Radioisotopes

    • Figure Market Size and Growth Rate of Therapeutic Radioisotopes

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine & Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine & Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Other

    • Table Global Nuclear Medicine & Radiopharmaceuticals Production by Major Regions

    • Table Global Nuclear Medicine & Radiopharmaceuticals Production Share by Major Regions

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Production Share by Major Regions in 2014

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Production Share by Major Regions in 2018

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Production Share by Major Regions in 2026

    • Table Global Nuclear Medicine & Radiopharmaceuticals Consumption by Major Regions

    • Table Global Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Regions

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Regions in 2014

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Regions in 2018

    • Figure Global Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Regions in 2026

    • Table North America Nuclear Medicine & Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Europe Nuclear Medicine & Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Nuclear Medicine & Radiopharmaceuticals market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Nuclear Medicine & Radiopharmaceuticals market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Nuclear Medicine & Radiopharmaceuticals market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Nuclear Medicine & Radiopharmaceuticals market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Nuclear Medicine & Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2026

    • Table North America Nuclear Medicine & Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table North America Nuclear Medicine & Radiopharmaceuticals Consumption by Major Countries from 2014 to 2026

    • Table North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2014

    • Figure North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2018

    • Figure North America Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2026

    • Figure United States Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Nuclear Medicine & Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Europe Nuclear Medicine & Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Europe Nuclear Medicine & Radiopharmaceuticals Consumption by Major Countries from 2014 to 2026

    • Table Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2014

    • Figure Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2018

    • Figure Europe Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2026

    • Figure Germany Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure France Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2026

    • Figure China Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandNuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure India Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Share by Major Countries in 2026

    • Figure GCC Countries Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Nuclear Medicine & Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Bracco Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging

    • Figure Sales and Growth Rate Analysis of Bracco Imaging

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Product and Service Introduction of Bracco Imaging

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

    • Table Company Profile and Development Status of Advanced Accelerator Applications

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Accelerator Applications

    • Figure Sales and Growth Rate Analysis of Advanced Accelerator Applications

    • Figure Revenue and Market Share Analysis of Advanced Accelerator Applications

    • Table Product and Service Introduction of Advanced Accelerator Applications

    • Table Company Profile and Development Status of Navidea

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea

    • Figure Sales and Growth Rate Analysis of Navidea

    • Figure Revenue and Market Share Analysis of Navidea

    • Table Product and Service Introduction of Navidea

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Jubilant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Product and Service Introduction of Jubilant Pharma

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

    • Table Company Profile and Development Status of SIEMENS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS

    • Figure Sales and Growth Rate Analysis of SIEMENS

    • Figure Revenue and Market Share Analysis of SIEMENS

    • Table Product and Service Introduction of SIEMENS

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation

    • Table Company Profile and Development Status of IBA Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group

    • Figure Sales and Growth Rate Analysis of IBA Group

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Product and Service Introduction of IBA Group


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.